HER2 in Gastric Cancer: An Immunohistochemical Study on Tissue Microarrays and the Coressponding Whole-Tissue Sections with a Supplemental Fish Study

被引:11
|
作者
Gasljevic, Gorana [1 ]
Lamovec, Janez [1 ]
Contreras, Juan Antonio [1 ]
Zadnik, Vesna [2 ]
Blas, Mateja [1 ]
Gasparov, Slavko [3 ,4 ]
机构
[1] Inst Oncol, Dept Pathol, Ljubljana 1000, Slovenia
[2] Inst Oncol, Canc Registry, Ljubljana 1000, Slovenia
[3] Univ Hosp Merkur, Dept Pathol, Zagreb 10000, Croatia
[4] Univ Zagreb, Sch Med, Zagreb 10000, Croatia
关键词
FISH; Gastric carcinoma; HER2; Immunohistochemistry; TMA; Whole sections; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; PROGNOSTIC-FACTOR; CARCINOMA; EXPRESSION; ASSOCIATION; VALIDATION; SURVIVAL; RECEPTOR;
D O I
10.1007/s12253-013-9654-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since focal HER2 expression is an issue in GC, TMA construction from the paraffin-embedded surgically-obtained tissue may not reflect its real status. The aim of this study was to assess the HER2 status in tissue microarrays (TMAs) and the corresponding whole sections using HercepTest immunohistochemistry (IHC), and to correlate it and to assess the concordance of HER2 IHC and fluorescence in situ hybridization (FISH) in TMAs. Concordance of the HER2 expression status for 302 cases of gastric cancer using 9 paired TMAs was evaluated using a 2-mm core size and 305 corresponding whole sections. Concordance of the IHC and FISH HER2 status was compared. In addition,, the HER2 status was compared to clinicopathological characteristics and patients' survival. Using the whole-section approach, HER2 over-expression was found in 25.2 % (HER2 3+ 6.6 %, HER2 2+ 18.7 %) of tumours. The overall concordance of IHC between the cores and the whole section was 84.9 %; 15.1 % of the tumours showed HER2 amplification. The overall concordance of IHC and FISH on cores was 75.7 %. The level of amplification correlated with the IHC score. Relationship between the intestinal and papillary types and tumour grade was observed for tumours with over-expression and amplification, whereas tumour location was related only to over-expression. There was a statistically significant difference in the overall survival of the patients, which was related to HER2 amplification. In conclusion, good concordance of the IHC HER2 results between tissue cores in TMA and whole sections, and excellent concordance of the IHC and FISH results on tissue cores was found. At least a part of the observed IHC HER2 heterogeneity could very likely be explained by fixation artifacts. With adequate fixation, a higher concordance of IHC HER2 between the cores and the whole sections can be expected. The TMA approach could enable an easier analysis of more than one representative tumour block.
引用
收藏
页码:855 / 865
页数:11
相关论文
共 50 条
  • [21] Combining simultaneously fish and immunolabeling on paraffin-embedded tissue sections for the study of HER2/neu: The development of a novel diagnostic approach
    Lottner, C
    Jung, R
    Schwarz, S
    Knuechel, R
    Hofstaedter, F
    Brockhoff, G
    CYTOMETRY PART A, 2004, 59A (01): : 84 - 84
  • [22] Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections
    Min Ye
    Dan Huang
    Qiongyan Zhang
    Weiwei Weng
    Cong Tan
    Guangqi Qin
    Wenhua Jiang
    Weiqi Sheng
    Lei Wang
    Cancer Cell International, 20
  • [23] Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections
    Ye, Min
    Huang, Dan
    Zhang, Qiongyan
    Weng, Weiwei
    Tan, Cong
    Qin, Guangqi
    Jiang, Wenhua
    Sheng, Weiqi
    Wang, Lei
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [24] Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients
    Peng, Zhi
    Liu, Yi
    Li, Yanyan
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Ming
    Li, Qingqing
    Shen, Lin
    BIOMARKERS IN MEDICINE, 2014, 8 (05) : 663 - 670
  • [25] HER2 Testing in Gastric Cancer - An Inter-laboratory IHC and FISH Correlation Study
    Tafe, L. J.
    Cao, J.
    Tsongalis, G. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 703 - 703
  • [26] Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma
    Drev, Primoz
    Grazio, Snjezana Frkovic
    Bracko, Matej
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (02) : 179 - 184
  • [27] Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks
    Pisula, Juan I.
    Datta, Rabi R.
    Valdez, Leandra Boerner
    Avemarg, Jan-Robert
    Jung, Jin-On
    Plum, Patrick
    Loeser, Heike
    Lohneis, Philipp
    Meuschke, Monique
    dos Santos, Daniel Pinto
    Gebauer, Florian
    Quaas, Alexander
    Walch, Axel
    Bruns, Christiane J.
    Lawonn, Kai
    Popp, Felix C.
    Bozek, Katarzyna
    BRITISH JOURNAL OF CANCER, 2023, 128 (07) : 1369 - 1376
  • [28] Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks
    Juan I. Pisula
    Rabi R. Datta
    Leandra Börner Valdez
    Jan-Robert Avemarg
    Jin-On Jung
    Patrick Plum
    Heike Löser
    Philipp Lohneis
    Monique Meuschke
    Daniel Pinto dos Santos
    Florian Gebauer
    Alexander Quaas
    Axel Walch
    Christiane J. Bruns
    Kai Lawonn
    Felix C. Popp
    Katarzyna Bozek
    British Journal of Cancer, 2023, 128 : 1369 - 1376
  • [29] Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis
    Zhang, Kecheng
    Cui, Jianxin
    Xi, Hongqing
    Bian, Shibo
    Ma, Liangang
    Shen, Weisong
    Li, Jiyang
    Wang, Ning
    Wei, Bo
    Chen, Lin
    PLOS ONE, 2015, 10 (08):
  • [30] Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study
    Prins, M. J. D.
    Ruurda, J. P.
    van Diest, P. J.
    van Hillegersberg, R.
    ten Kate, F. J. W.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (01) : 26 - 32